# Androcur® (Cyproterone Acetate) and Meningioma Development: a Genotype-environment Association Study

> **NCT04372095** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 2000 (estimated)

## Conditions studied

- Meningioma

## Interventions

- **PROCEDURE:** oral smears

## Key facts

- **NCT ID:** NCT04372095
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-06
- **Primary completion:** 2025-04-19
- **Final completion:** 2025-04-19
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2023-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04372095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04372095, "Androcur® (Cyproterone Acetate) and Meningioma Development: a Genotype-environment Association Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04372095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*